For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.

TitleMagnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.
Publication TypeJournal Article
Year of Publication2018
AuthorsChiang GC, Kovanlikaya I, Choi C, Ramakrishna R, Magge R, Shungu DC
JournalFront Neurol
Volume9
Pagination33
Date Published2018
ISSN1664-2295
Abstract

Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.

DOI10.3389/fneur.2018.00033
Alternate JournalFront Neurol
PubMed ID29459844
PubMed Central IDPMC5807339
Grant ListR01 MH075895 / MH / NIMH NIH HHS / United States
R01 MH100005 / MH / NIMH NIH HHS / United States
S10 OD021782 / OD / NIH HHS / United States